It's a cohort analysis of 24 people in a pII trial powered to test for safety.
If this company's announcements aren't designed to excite unsophisticated investors with statistically meaningless information, then they certainly do a very good job of it accidentally.
Ann: MSB Therapy Shows Benefit In First Cohort Of RA Patients, page-3
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $3.964M | 4.161M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 67604 | 94.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 9595 | 4 |
View Market Depth
| Last trade - 15.52pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |